NewsBenzinga랜턴 파마의 스트라라이트 테라퓨틱스, LP-184 1a상 GBM 데이터 발표···확장 권장 용량 및 임상 적용 가능한 1b/2a상 시험 계획을 위한 투여 전략 수립 랜턴 파마의 스트라라이트 테라퓨틱스, LP-184 1a상 GBM 데이터 발표···확장 권장 용량 및 임상 적용 가능한 1b/2a상 시험 계획을 위한 투여 전략 수립 Benzinga 2026.11.10 13:49 (GMT+0) Open on Benzinga Other news A-Share Close: ChiNext Index Down Over 1% After Intraday Reversal, More Than 4,100 Stocks Fall Ark Invest Makes Big Crypto-Related Buys Yesterday While Selling $84.8M in Nvidia Stock Abraxas Capital Closes Most of Its Hyperliquid Shorts, Account Value Down to Just $22.4 Million Nvidia Falls 35% From Record High, Short Sellers Sit on $24 Billion in Paper Profits Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory
Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips
Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory